Stay updated on Pembrolizumab+Ferumoxytol MRI in NSCLC Brain Metastases Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab+Ferumoxytol MRI in NSCLC Brain Metastases Clinical Trial page.

Latest updates to the Pembrolizumab+Ferumoxytol MRI in NSCLC Brain Metastases Clinical Trial page
- Check7 days agoChange DetectedThe page shows a new revision label, updating from Revision: v3.5.4 to Revision: v3.5.5, indicating a system/template update. This change does not modify the study details, eligibility criteria, or results.SummaryDifference0.1%

- Check14 days agoNo Change Detected
- Check21 days agoNo Change Detected
- Check28 days agoChange DetectedA new revision tag Revision: v3.5.4 was added and the previous Revision: v3.5.3 was removed, reflecting an update to the page's versioning metadata. This indicates a maintenance update to the page's documentation rather than changes to study content.SummaryDifference0.1%

- Check43 days agoChange DetectedThe page revision was updated from v3.5.2 to v3.5.3, signaling a small internal version update to the page. There are no changes to the study data or displayed content.SummaryDifference0.1%

- Check57 days agoChange DetectedThe page revision was updated to v3.5.2, replacing the previous v3.5.0 revision.SummaryDifference0.1%

- Check86 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0.SummaryDifference0.1%

- Check93 days agoChange DetectedThe page now displays revision: v3.4.3 in place of the previous v3.4.2.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab+Ferumoxytol MRI in NSCLC Brain Metastases Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab+Ferumoxytol MRI in NSCLC Brain Metastases Clinical Trial page.